Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice

Immunity

Volumn 10, Issue 2, 1999, Pages 207-217

  Nakagawa, Terry Y ^a   Brissette, William H ^b   Lira, Paul D ^b   Griffiths, Richard J ^b   Petrushova, Nina ^b   Stock, Jeffrey ^b   McNeish, John D ^b   Eastman, Susan E ^a   Howard, Edward D ^a   Clarke, Sally R M ^a   Rosloniec, Edward F ^c   Elliott, Eileen A ^b   Rudensky, Alexander Y ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; COLLAGEN; CYSTEINE PROTEINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; B LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; KNOCKOUT MOUSE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION;

EID: 2442549710     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80021-7     Document Type: Article

References (45)

1. Avva, R.R., and Cresswell, P. (1994). In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1, 763-774.
2. Barrett, A.J. (1987). The cystatins: A new class of peptidase inhibitors. Trends Biochem. Sci. 12, 193-196.
3. Baumgart, M., Moos, V., Schuhbauer, D., and Muller, B. (1998). Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. Proc. Natl. Acad. Sci., USA 95, 6936-6940.
4. Bennett, K., Levine, T., Ellis, J.S., Peanasky, R.J., Samloff, I.M., Kay, J., and Chain, B.M. (1992). Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22, 1519-1524.
5. Bevec, T., Stoka, V., Pungercic, G., Dolenc, I., and Turk, V. (1996). Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183, 1331-1338.
6. Blum, J.S., and Cresswell, P. (1988). Role of intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci., USA 85, 3975-3980.
7. Brachet, V., Raposo, G., Amigorena, S., and Mellman, I. (1997). Li chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell. Biol. 137, 51-65.
8. q mice. J. Immunol. 152, 3088-3097.
9. Bromme, D., Rinne, R., and Kirschke, H. (1991). Tight-binding inhibition of cathepsin S by cystatins. Biomed. Biochim. Acta. 50, 631-635.
10. Cresswell, P. (1996). Invariant chain structure and MHC class II function. Cell 84, 505-507.
11. Denzin, L.K, Hammond, C., and Cresswell, P. (1996). HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184, 2153-2165.
12. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H.L., and Villadangos, J.A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA 95, 4516-4521.
13. Fineschi, B., Sakaguchi, K., Appella, E., and Miller, J. (1996). The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J. Immunol. 157, 3211-3215.
14. Germain, R.N., and Hendrix, L.H. (1991). MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353, 134-139.
15. 4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 92, 517-521.
16. Griffiths, R.J., Smith, M.A., Roach, M.L., Stock, J.L., Stam, E.J., Milici, A.J., Scampoli, D.N., Eskra, J.D., Byrum, R.S., Koller, B.H., et al. (1997). Collagen-induced arthritis is reduced in 5-lipoxygenase- Activating protein-deficient mice. J. Exp. Med. 185, 1123-1129.
17. Grubin, C.E., Kovats, S., DeRoos, P., and Rudensky, A.Y. (1997). Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity 7, 197-208.
18. Query, J.C., Ria, F., and Adorini, L. (1996). Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J. Exp. Med. 183, 751-757.
19. Kleijmeer, M.J., Morkowski, S., Griffith, J.M., Rudensky, A.Y., and Geuze, H.J. (1997). MHC class II compartments (MIICs) in human and mouse lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139, 639-649.
20. Koch, N., Koch, S., and Hammerling, G.J. (1982). La invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature 299, 644-645.
21. Kovats, S., Grubin, C.E., Eastman, S., DeRoos, P., Dongre, A., Van Kaer, L., and Rudensky, A.Y. (1998). Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo. J. Exp. Med. 187, 245-251.
22. Liljedahl, M., Winqvist, O., Surh, C.D., Wong, P., Ngo, K., Teyton, L., Peterson, P.A., Brunmark, A., Rudensky, A.Y., Fung-Leung, W.P., et al. (1998). Altered antigen presentation in mice lacking H2-O. Immunity 8, 233-243.
23. Loss, G.E., Jr., and Sant, A.J. (1993). Invariant chain retains MHC class II molecules in the endocytic pathway. J. Immunol. 150, 3187- 3197.
24. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E.R., Lyman, S.D., Shortman, K., and McKenna, H.J. (1996). Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell sub-populations identified. J. Exp. Med. 184, 1953-1962.
25. Marie, M.A., Taylor, M.D., and Blum, J.S. (1994). Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA 91, 2171-2175.
26. Mason, R.W., Wilcox, D., Wikstrom, P., and Shaw, E.N. (1989). The identification of active forms of cysteine proteinases in Kirsten- virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. Biochem. J. 257, 125-129.
27. Merz, G.S., Benedikz, E., Schwenk, V., Johansen, T.E., Vogel, L.K., Rushbrook, J.I., and Wisniewski, H.M. (1997). Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J. Cell. Physiol. 173, 423-432.
28. Moreno, J., Vignali, D.A., Nadimi, F., Fuchs, S., Adorini, L, and Hammerling, G.J. (1991). Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147, 3306-3313.
29. Morkowski, S., Raposo, G., Kleijmeer, M., Geuze, HJ., and RudenSky, A.Y. (1997). Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments. Eur. J. Immunol. 27, 609-617.
30. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J. Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: Critical role in li degradation and CD4 T cell selection in the thymus. Science 280, 450-453.
31. Neefjes, J.J., and Ploegh, H.L. (1992). Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant alpha-beta heterodimers in endosomes. EMBO J. 11, 411-416.
32. Palmer, J.T., Rasnick, D., Klaus, J.L., and Bromme, D. (1995). Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38, 3193-3196.
33. Pierre, P., and Mellman, I. (1998). Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93, 1135-1145.
34. Pulendran, B., Lingappa, J., Kennedy, M.K., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C.R., and Maraskovsky, E. (1997). Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand- Treated mice. J. Immunol. 159, 2222-2231.
35. Riese, R.J., Wolf, P.R., Bromme, D., Natkin, L.R., Villadangos, J.A., Ploegh, H.L., and Chapman, H.A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357-366.
36. Riese, R.J., Mitchell, R.N., Villadangos, J.A., Shi, G.P., Palmer, J.T., Karp, E.R., Desanctis, G.T., Ploegh, H.L., and Chapman, H.A. (1998). Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101, 2351-2363.
37. Roach, M.L., Stock, J.L., Byrum, R., Koller, B.H., and McNeish, J.D. (1995). A new embryonic stem cell line from DBA/1 lacJ mice allows genetic modification in a murine model of human inflammation. Exp. Cell Res. 221, 520-525.
38. d-restricted hen egg lysozyme determinant. Eur. J. Immunol. 26, 1656-1659.
39. Rodriguez, G.M., and Diment, S. (1995). Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin. Eur. J. Immunol. 25, 1823-1827.
40. Rosloniec, E.F., Whittington, K.B., Brand, D.D., Myers, L.K., and Stuart, J.M. (1996). Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Cell. Immunol. 172, 21-28.
41. Rudensky, A.Y., Maric, M., Eastman, S., Shoemaker, L., DeRoos, P.C., and Blum, J.S. (1994). Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1, 585-594.
42. Stebbins, C.C., Peterson, M.E., Suh, W.M., and Sant, AJ. (1996). DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157, 4892-4898.
43. van Noort, J.M., and Jacobs, MJ. (1994). Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules. Eur. J. Immunol. 24, 2175-2180.
44. Villadangos, J.A., Riese, R.J., Peters, C., Chapman, H.A., and Ploegh, H.L. (1997). Degradation of mouse invariant chain: Roles of cathepsin S and D and the influence of major histocompatibility complex (MHC) polymorphism. J. Exp. Med. 186, 549-560.
45. Watts, C. (1997). Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821-850.